Reports for SIVEM PHARMACEUTICALS ULC
Company Name
SIVEM PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
378 |
|
| Actual shortage: | 25 (7%) | |
| Anticipated shortage: | 6 (2%) | |
| Avoided shortage: | 14 (4%) | |
| Resolved: | 333 (88%) | |
Discontinuation Reports |
107 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 100 (93%) | |
| Reversed: | 7 (7%) | |
Late reports |
83 (17%) |
|
Overdue reports |
6 (19%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LOSARTAN HCT | 12.5MG 100MG | TABLET | Resolved | 2019-02-01 | 2019-03-11 | 74303 |
| TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Avoided shortage | 2019-02-22 | 2019-03-11 | 76655 |
| ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-02-01 | 2019-03-12 | 74246 |
| RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-02-15 | 2019-03-12 | 75988 |
| CELECOXIB | 200MG | CAPSULE | Resolved | 2019-02-12 | 2019-03-20 | 75387 |
| LOSARTAN | 100MG | TABLET | Avoided shortage | 2019-03-11 | 2019-03-25 | 78311 |
| TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Resolved | 2019-03-25 | 2019-04-22 | 79382 |
| GABAPENTIN | 800MG | TABLET | Resolved | 2019-01-14 | 2019-04-30 | 72156 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2019-02-01 | 2019-04-30 | 74341 |
| SERTRALINE | 25MG | CAPSULE | Resolved | 2019-02-12 | 2019-04-30 | 75420 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2019-02-15 | 2019-04-30 | 76016 |
| IRBESARTAN HCT | 12.5MG 150MG | TABLET | Resolved | 2019-04-01 | 2019-05-06 | 80252 |
| LOSARTAN | 50MG | TABLET | Resolved | 2019-02-12 | 2019-05-06 | 75405 |
| LOSARTAN | 100MG | TABLET | Resolved | 2019-02-15 | 2019-05-06 | 75993 |
| PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2019-04-09 | 2019-05-07 | 80860 |
| CELECOXIB | 200MG | CAPSULE | Resolved | 2019-01-07 | 2019-05-13 | 71382 |
| GABAPENTIN | 600MG | TABLET | Resolved | 2018-12-17 | 2019-05-13 | 69781 |
| QUETIAPINE | 100MG | TABLET | Resolved | 2019-04-09 | 2019-05-21 | 80880 |
| LOSARTAN | 100MG | TABLET | Avoided shortage | 2019-05-17 | 2019-05-24 | 84342 |
| ROSUVASTATIN | 5MG | TABLET | Resolved | 2019-02-12 | 2019-05-25 | 75408 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-03-26 | 2018-03-26 | 44064 |
| MONTELUKAST | 4MG | TABLET (CHEWABLE) | Discontinued | 2018-03-08 | 2018-04-09 | 42304 |
| MONTELUKAST | 10MG | TABLET | Discontinued | 2018-03-08 | 2018-04-09 | 42310 |
| MONTELUKAST | 5MG | TABLET (CHEWABLE) | Discontinued | 2018-03-08 | 2018-04-09 | 42307 |
| OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2018-05-01 | 2018-06-26 | 47840 |
| OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2018-05-01 | 2018-06-26 | 47843 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53291 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53294 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53297 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53300 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53303 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53306 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53318 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53321 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53324 |
| MEMANTINE | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53283 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53327 |
| NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-06-29 | 2018-06-30 | 53333 |
| NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-06-29 | 2018-06-30 | 53339 |
| ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53380 |